Dermatitis, Seborrheic: all 58 studies

Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.

• TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 YearsNot yet recruitingNCT07860788Not applicable
• The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp.RecruitingNCT07734441Early Phase 1
• Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic DermatitisNot yet recruitingNCT07683806Phase 3
• A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant PatientsRecruitingNCT07641686Not applicable
• Sebum Metabolomics and Lipidomics for Clinical ApplicationsNot yet recruitingNCT07549828Not applicable
• ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic DermatitisRecruitingNCT07404033Phase 1
• The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic DermatitisRecruitingNCT05942248Not applicable
• PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular RosaceaTerminatedNCT06013371Phase 2Results posted
• Ruxolitinib in Seborrheic DermatitisCompletedNCT05787860Phase 2Results posted
• Cleansing Device for the Treatment of Scalp and Hair ConditionsTerminatedNCT05319444Not applicableResults posted
• Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)CompletedNCT04973228Phase 3Results posted
• Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic DermatitisCompletedNCT04445987Phase 2Results posted
• Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic DermatitisCompletedNCT04091646Phase 2Results posted
• Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and AdultCompletedNCT03830177Phase 1/2Results posted
• A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's DiseaseCompletedNCT03582137Phase 2Results posted
• A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic DermatitisCompletedNCT03567980Phase 4Results posted
• DUS on the Prescribing Indications for CPA/EE in 5 European CountriesCompletedNCT02494297Results posted
• Promiseb Topical Cream for Cradle CapCompletedNCT01214434Phase 4Results posted
• Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% ShampooCompletedNCT01203189Not applicableResults posted
• Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic DermatitisCompletedNCT00862654Phase 3Results posted
• STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%CompletedNCT00703846Phase 4Results posted
• A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic DermatitisCompletedNCT00403559Phase 2Results posted
• Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic DermatitisCompletedNCT07906886Phase 4
• Effect of 0.75% Piroctone Olamine Shampoo on the Hair and Scalp Microbiota of Hijab-Wearing Women With Seborrheic Dermatitis in IndonesiaCompletedNCT07802808Phase 4
• A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisCompletedNCT07576023Not applicable
• Ozonated Oil Emulsion for Seborrhea in WomenCompletedNCT07559617Not applicable
• Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic DermatitisCompletedNCT07433907Not applicable
• Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and DermatologistsCompletedNCT07428915
• Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.CompletedNCT07297446
• Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic DermatitisCompletedNCT07063615Not applicable
• Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous StatesCompletedNCT06578962
• HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
• Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of ScalpCompletedNCT05105139
• A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in EuropeCompletedNCT04925180
• Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory DermatosisCompletedNCT04472546Not applicable
• Effects on the Scalp Microbiota of a 1% Selenium Disulfide and 1% Salicylic Acid Shampoo After 2% Ketaconazole Foaming Gel Treatment for Scalp Seborrheic DermatitisCompletedNCT04057950Not applicable
• Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis PatientsCompletedNCT03807453
• Omiganan Twice a Day (BID) in Patients With Facial Seborrheic DermatitisStatus unknownNCT03688971Phase 2
• Pilot Study for the Use of Photodynamic Therapy in the Treatment of Seborrheic DermatitisCompletedNCT03114111Early Phase 1
• A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic DermatitisCompletedNCT02749383Phase 2
• Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic DermatitisCompletedNCT02656368Not applicable
• Neurobiology of the Scalp in Seborrheic DermatitisCompletedNCT02349854
• Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic DermatitisCompletedNCT02004860Phase 3
• Safety and Efficacy Study in Subjects With Seborrheic DermatitisCompletedNCT01703793Phase 2
• Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic DermatitisCompletedNCT01591070Phase 4
• Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing ExacerbationTerminatedNCT01315951Not applicable
• Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male VolunteersCompletedNCT01254162Phase 2
• HIV Indicator Diseases Survey Across Europe - UK ArmStatus unknownNCT01196468
• Efficacy and Safety of Low-dose Oral Isotretinoin for SeborrheaStatus unknownNCT01139749Phase 4
• Two Topical K40 Formulations in Adults With Seborrhoeic Dermatitis (SD) of the ScalpCompletedNCT01137630Phase 2/3
• K301 for the Treatment of Seborrhoeic Eczema (SE) of the ScalpCompletedNCT01137331Phase 3
• Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the FaceStatus unknownNCT01024374
• Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive DermatosisStatus unknownNCT01011621Phase 3
• The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of PhotodamageCompletedNCT00991198Phase 2
• HairMax LaserComb Open Label Study to Treat Seborrheic DermatitisCompletedNCT00830908Not applicable
• Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian PatientsStatus unknownNCT00767546Phase 1
• Efficacy and Safety of ASF1057 in the Treatment of Seborrhoeic DermatitisCompletedNCT00565279Phase 3
• A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the FaceCompletedNCT00408330Phase 2

← Dermatitis, Seborrheic overview